Need help choosing the right HIPAA software?
Tell us about your practice and we'll recommend the best tools for you.
Intuitive, configurable EHR and practice management for small and mid-size behavioral health practices
Prescription digital therapeutic for substance use disorder
Cloud-based EHR and practice management platform from Qualifacts, configured for small and mid-size behavioral health and human services practices, with configurable clinical workflows, integrated billing and revenue cycle management, telehealth, e-prescribing, and Qualifacts iQ AI documentation tools. InSync Healthcare Solutions was acquired by Qualifacts in 2021 and the product is now sold and supported as the Qualifacts InSync EHR; the legacy insynchcs.com site now resolves to Qualifacts.
reSET is a prescription digital therapeutic that delivers a 12-week course of cognitive behavioral therapy with contingency management through a smartphone app, as an adjunct to outpatient treatment for substance use disorder in adults. It was developed by Pear Therapeutics and in 2017 became the first prescription digital therapeutic authorized by the FDA, through the De Novo pathway. Pear Therapeutics filed for Chapter 11 bankruptcy in April 2023 and its assets were sold at auction, but reSET itself is still sold and supported today: PursueCare relaunched it as RESET in October 2024, and XRHealth acquired PursueCare, including RESET and RESET-O, in November 2026.
Need help choosing the right HIPAA software?
Tell us about your practice and we'll recommend the best tools for you.